Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif
about
TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activationA novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor receptor-associated factor 6Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesisSite-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activationTAK1-dependent signaling requires functional interaction with TAB2/TAB3Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaBReceptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6RANK is essential for osteoclast and lymph node developmentNew insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancerThe RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKLGambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathwayThe intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the gamesThe role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption.RANK-RANKL signalling in cancerA functional interaction between the p75 neurotrophin receptor interacting factors, TRAF6 and NRIF.Smad-dependent mechanisms of inflammatory bone destructionEffects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) familyDisulfiram attenuates osteoclast differentiation in vitro: a potential antiresorptive agentAnalysis of expressed sequence tags from Maize mosaic rhabdovirus-infected gut tissues of Peregrinus maidis reveals the presence of key components of insect innate immunity.Ubiquitin-mediated signalling and Paget's disease of bone.TRAF6 is required for generation of the B-1a B cell compartment as well as T cell-dependent and -independent humoral immune responses.Development of cell-based high-throughput assays for the identification of inhibitors of receptor activator of nuclear factor-kappa B signaling.Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interactionSesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products.Pathway-based association analyses identified TRAIL pathway for osteoporotic fractures.The Ran-binding protein RanBPM can depress the NF-κB pathway by interacting with TRAF6.Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases.Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis.Crotepoxide chemosensitizes tumor cells through inhibition of expression of proliferation, invasion, and angiogenic proteins linked to proinflammatory pathwayModification of cysteine 179 of IkappaBalpha kinase by nimbolide leads to down-regulation of NF-kappaB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agentsReceptor activator of NF-{kappa}B (RANK) cytoplasmic IVVY535-538 motif plays an essential role in tumor necrosis factor-{alpha} (TNF)-mediated osteoclastogenesis.Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond.Regulatory mechanisms of osteoblast and osteoclast differentiation.Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2Caveolin-1 regulates osteoclastogenesis and bone metabolism in a sex-dependent mannerNuclear transcription factor-kappaB in Hodgkin's disease.NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responsesBharangin, a diterpenoid quinonemethide, abolishes constitutive and inducible nuclear factor-κB (NF-κB) activation by modifying p65 on cysteine 38 residue and reducing inhibitor of nuclear factor-κB α kinase activation, leading to suppression of NF-
P2860
Q22253885-29048B7F-1706-4708-BE14-7FD00A81C997Q24292059-D2E1CECF-B88E-4F0E-9DAF-478017D9C0E5Q24311417-6FA7B33A-4D5C-4B1E-A6EF-20B0D5AFF6A9Q24321363-A80BAE80-7800-4CB4-B1EA-71D2D16808CFQ24324222-8B35CCCB-4CFC-4627-97F7-16F9E442A3E0Q24534564-3C44152D-F3EF-44C4-98EF-4C8AB79B0D15Q24537518-9A632F73-CFF5-4C41-9DEB-8F2514F48313Q24598872-28C86E2E-CDF1-4169-B868-F340FE0CA1B5Q24619151-8AD5CB91-9E3A-4C6D-8215-E8F10BB17D56Q24654977-A6C70656-F62D-45BC-9E67-3675AD17EE12Q24678660-60EDE527-6EFE-481B-8DB8-22DBFA14C703Q24683018-0F8CFAAD-388A-48AC-A864-71876B993AABQ24805207-3C8D1157-1653-4F78-B047-59B9DE1D0EEDQ26747442-3ABEF344-1B5B-487E-8BDF-2110A4BFE9CAQ27919649-36231905-DAEB-4902-B491-4839E9C19F3FQ28066288-C32D6B66-F6AF-43E9-8E2C-4716428D2DAFQ28207648-C069EE36-B4A8-4B01-8ED6-05EBDC3AE063Q28208696-DC64F8E1-C946-427E-9AB2-8EB6E97D9EB8Q28546890-19A1F621-9F2A-4FB0-AE0D-405A14DA7059Q30993599-748B279A-EC90-499A-8613-D147289E48ADQ33307880-00CC8AA6-0D73-4DE8-BC1E-34CCB4295EA8Q33416004-B18817D2-C23E-4E21-9F09-54403FF473A8Q33738074-48028A7A-7AE9-4030-8ED7-E16149122E19Q33782305-756D0430-BF0F-4780-950D-1E442FCF5C8EQ33886695-320ADFF1-4F75-4CB0-8381-965BFA073F41Q33957047-917C56E0-356E-4FAA-BF61-8806DBD32624Q33961554-D16BE338-866A-478F-BCFF-1EF199D3392FQ33976649-DE04DC18-1852-407C-B349-A2A658DE182AQ34086847-5422A434-26B3-47B6-8F95-97FD94B62BF5Q34090842-B596373E-CB69-4FF4-89C9-1582F169E363Q34094406-BB3D8F0E-4615-4821-923E-CF62A1AD2B33Q34285044-0DC5C991-0835-4277-9B42-3B495DD06D28Q34333628-0E6C6394-4A15-477B-823D-F0EC408A7DADQ34366449-602A4C39-DA5D-45AA-AB8C-04A9DB2A36DFQ34728971-3E0F88C6-F871-491B-AC97-24AF3E995B30Q35105452-46C9AB7C-B198-46D6-807F-308CF8015F89Q35173015-DB4A5D0B-6FA0-49E1-9C7C-5980DF15C8C5Q35175282-5F4AE63E-CD7D-4362-A826-B67AAF6E0F6BQ35208356-605921E2-9FD1-4D6F-AC3E-F37D05B26FD4Q35415849-9F49356A-B233-4714-BDD1-CB37376D3DD9
P2860
Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Activation of NF-kappaB by RAN ...... novel TRAF6 interaction motif
@ast
Activation of NF-kappaB by RAN ...... novel TRAF6 interaction motif
@en
Activation of NF-kappaB by RAN ...... novel TRAF6 interaction motif
@nl
type
label
Activation of NF-kappaB by RAN ...... novel TRAF6 interaction motif
@ast
Activation of NF-kappaB by RAN ...... novel TRAF6 interaction motif
@en
Activation of NF-kappaB by RAN ...... novel TRAF6 interaction motif
@nl
prefLabel
Activation of NF-kappaB by RAN ...... novel TRAF6 interaction motif
@ast
Activation of NF-kappaB by RAN ...... novel TRAF6 interaction motif
@en
Activation of NF-kappaB by RAN ...... novel TRAF6 interaction motif
@nl
P2093
P2860
P3181
P356
P1476
Activation of NF-kappaB by RAN ...... novel TRAF6 interaction motif
@en
P2093
P2860
P304
P3181
P356
10.1074/JBC.274.12.7724
P407
P577
1999-03-19T00:00:00Z